Resultados da pesquisa - David Mutimer

Refinar resultados
  1. 1
    Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

    Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient Por David Mutimer

    Publicado em 2000
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Regular review: Treatment of chronic hepatitis

    Regular review: Treatment of chronic hepatitis Por Paul Gow, David Mutimer

    Publicado em 2001
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Hepatitis C Virus and Nonliver Solid Organ Transplantation

    Hepatitis C Virus and Nonliver Solid Organ Transplantation Por Marco Carbone, David Mutimer, James Neuberger

    Publicado em 2012
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

    Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C Por M Wali, Rebecca Harrison, Paul Gow, David Mutimer

    Publicado em 2002
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

    Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine Por Roger Ling, David Mutimer, Mélika Ben Ahmed, Elizabeth H. Boxall, Elwyn Elias, Geoffrey Dusheiko, Tim J. Harrison

    Publicado em 1996
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis

    Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis Por David Mutimer, Shelley P. M. Fussey, Stephen J. Yeaman, Peter J. Kelly, Oliver James, Margaret F. Bassendine

    Publicado em 1989
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Management of Antiviral Resistance in Patients with Chronic Hepatitis B

    Management of Antiviral Resistance in Patients with Chronic Hepatitis B Por Stephen Locarnini, Angelos Hatzakis, Jenny Heathcote, Emmet B. Keeffe, T. Jake Liang, David Mutimer, Jean‐Michel Pawlotsky, Fabien Zoulim

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells

    Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells Por Zania Stamataki, Claire Shannon‐Lowe, Jean Shaw, David Mutimer, Alan B. Rickinson, John Gordon, David H. Adams, Peter Balfe, Jane A. McKeating

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

    New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England Por Ross Harris, Natasha K. Martin, Eleanor A. Rand, Sema Mandal, David Mutimer, Peter Vickerman, Mary Ramsay, Daniela De Angelis, Matthew Hickman, H Harris

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Impact of Donor Age and Year of Transplantation on Graft and Patient Survival Following Liver Transplantation for Hepatitis C Virus

    Impact of Donor Age and Year of Transplantation on Graft and Patient Survival Following Liver Transplantation for Hepatitis C Virus Por David Mutimer, Bridget Gunson, John Chen, Juan Berenguer, P. Neuhaus, D. Castaing, Juan Carlos Garcı́a-Valdecasas, Mauro Salizzoni, Gonzalez E. Moreno, Darius F. Mirza

    Publicado em 2006
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

    Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus Por Robert Perrillo, Hie-Won Hann, David Mutimer, Bernard Willems, Nancy Leung, William M. Lee, Alison Moorat, Stephen D. Gardner, Mary Woessner, Eric Bourne, Carol Brosgart, Eugene R. Schiff

    Publicado em 2003
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    <scp>UK</scp> consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis <scp>C</scp> infected patients

    <scp>UK</scp> consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis <scp>C</scp> infected patients Por Prakash Ramachandran, Andrew Fraser, Kosh Agarwal, A. Austin, Ashley Brown, Graham R. Foster, Ray Fox, Peter Hayes, Clifford Leen, Peter R. Mills, David Mutimer, Stephen Ryder, John Dillon

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

    Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis Por Graham R. Foster, William L. Irving, Michelle Cheung, Alex J Walker, Ben Hudson, Suman Verma, John McLauchlan, David Mutimer, Ashley Brown, William Gelson, Douglas MacDonald, Kosh Agarwal

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

    Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis Por Michelle Cheung, Alex J Walker, Ben Hudson, Suman Verma, John McLauchlan, David Mutimer, Ashley Brown, William Gelson, Douglas MacDonald, Kosh Agarwal, Graham R. Foster, William L. Irving

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

    High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis Por Massimo Puoti, Graham R. Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Chang, Samuel S. Lee, Rui Marinho, Jean‐François Dufour, Stanislas Pol, Christophe Hézode, Stuart C. Gordon, Simone I. Strasser, Paul J. Thuluvath, Zhenzhen Zhang, Sandra Lovell, Edward Tam, Federico Mensa

    Publicado em 2018
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

    Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response Por Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown, Fabien Zoulim, David Mutimer, Katja Deterding, Jörg Petersen, Wolf Peter Hofmann, Marı́a Buti, Teresa Santantonio, Florian van Bömmel, Pierre Pradat, Ye Htun Oo, Marc Luetgehetmann, Thomas Berg, Bettina E. Hansen, Heiner Wedemeyer, Harry L.A. Janssen

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    British <scp>HIV A</scp>ssociation guidelines for the management of hepatitis viruses in adults infected with <scp>HIV</scp> 2013

    British <scp>HIV A</scp>ssociation guidelines for the management of hepatitis viruses in adults infected with <scp>HIV</scp> 2013 Por Ed Wilkins, Mark Nelson, Kosh Agarwal, Dola Awoyemi, Eleanor Barnes, Sanjay Bhagani, Gary Brook, Ashley Brown, Sheena Castelino, Graham Cooke, Fabiola Martin, Anna María Geretti, Robert A. James, Ranjababu Kulasegaram, Clifford Leen, David Mutimer, Chloe Orkin, Emma Page, Adrian Palfreeman, Padmasayee Papineni, Alison Rodger, C. Y. William Tong

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

    Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection Por Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter Angus, Edward Gane, Jia‐Horng Kao, Parvez Mantry, David Mutimer, K. Rajender Reddy, Tram T. Tran, Yiran Hu, Abhishek Gulati, Preethi Krishnan, Emily O. Dumas, Ariel Porcalla, Nancy S. Shulman, Wei Liu, Suvajit Samanta, Roger Trinh, Xavier Forns

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Glecaprevir/Pibrentasvir in patients with chronic <scp>HCV</scp> genotype 3 infection: An integrated phase 2/3 analysis

    Glecaprevir/Pibrentasvir in patients with chronic <scp>HCV</scp> genotype 3 infection: An integrated phase 2/3 analysis Por Steven L. Flamm, David Mutimer, Armen Asatryan, Stanley Wang, Jürgen K. Rockstroh, Yves Horsmans, Paul Y. Kwo, Ola Weiland, Erica Villa, Jeong Heo, Edward Gane, Stephen Ryder, Tania M. Welzel, Peter Ruane, Kosh Agarwal, Teresa I. Ng, Zhenyi Xue, Sandra Lovell, Preethi Krishnan, Sarah Kopecky‐Bromberg, Roger Trinh, Federico Mensa, David Wyles

    Publicado em 2018
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans

    Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans Por Christabel Kelly, Leo Swadling, Stefania Capone, Anthony Brown, Rachel Richardson, John Halliday, Annette von Delft, Ye Htun Oo, David Mutimer, Ayako Kurioka, Felicity Hartnell, J. R. Collier, Virginia Ammendola, Mariarosaria Del Sorbo, Fabiana Grazioli, Maria Luisa Esposito, Stefania Di Marco, Loredana Siani, Cinzia Traboni, Adrian V. S. Hill, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Antonella Folgori, Paul Klenerman, Eleanor Barnes

    Publicado em 2015
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: